REPLIGEN CORP — Director's Dealing 2021

Aug 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2021-08-17

Reporting Person: Hunt Anthony (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-17	Common Stock	G	1000	$0.00	Disposed	189495	Direct

Footnotes

F1: The shares were disposed of in connection with a bona fide gift by the Reporting Person to a donor advised fund.